ABL Bio Inc (298380) — Cash Flow Quality Index
ABL Bio Inc (298380) has a Cash Flow Quality Index of 0.96x as of June 2025. Operating cash flow of ₩38.30 Billion is below net income of ₩39.78 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ABL Bio Inc cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ABL Bio Inc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for ABL Bio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 298380 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ABL Bio Inc (2022–2022)
Year-by-year earnings quality comparison for ABL Bio Inc. For live market cap and the full company financial profile, see ABL Bio Inc (298380) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 22.48x | ₩72.13 Billion | ₩3.21 Billion | — |